Paunzhausen, Germany

Andreas Hohlbaum

USPTO Granted Patents = 22 

 

 

Average Co-Inventor Count = 4.7

ph-index = 6

Forward Citations = 120(Granted Patents)


Company Filing History:


Years Active: 2011-2022

Loading Chart...
Loading Chart...
Loading Chart...
22 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Andreas Hohlbaum

Introduction: Andreas Hohlbaum, located in Paunzhausen, Germany, is a prolific inventor with a remarkable portfolio of 22 patents. His work primarily focuses on innovative methods for preventing and treating various disorders through biochemical approaches. Hohlbaum's contributions have the potential to significantly impact the field of medicine, particularly concerning immune responses.

Latest Patents: Among his latest patents, one prominent innovation is the development of methods for treating disorders by inhibiting the binding of IL-4 and/or IL-13 to their respective receptors. This method involves administering a therapeutically effective amount of a composition comprising a protein that inhibits the ligands' binding. Specifically, this approach targets conditions associated with an increase in the Th2 immune response, aiming to treat allergic asthma, rhinitis, lung fibrosis, chronic obstructive pulmonary disease, and more. Another notable patent includes tear lipocalin muteins that bind to IL-4 receptor alpha. This invention presents novel muteins derived from human tear lipocalin, detailing specific amino acid combinations that enable these muteins to inhibit binding effectively. This patent not only provides a unique therapeutic avenue but also includes methods for producing the muteins and their corresponding nucleic acids.

Career Highlights: Throughout his career, Hohlbaum has made significant strides in pharmaceutical research and development. He has been associated with Pieris Pharmaceuticals GmbH and Pieris AG, where he has likely collaborated with other leading researchers in the field. His focus on immunological responses and therapeutic interventions showcases his dedication to advancing medical science.

Collaborations: Hohlbaum has worked alongside talented individuals such as Gabriele Matschiner and Stefan Trentmann, contributing to a collaborative environment that fosters innovation and development. These partnerships play a crucial role in the advancement of research and the successful implementation of groundbreaking therapies.

Conclusion: Andreas Hohlbaum's contributions to the field of medicine through his inventive patents demonstrate his commitment to addressing complex health disorders. His innovative approaches to inhibiting immune responses represent a significant leap forward in therapeutic methods. With his continued efforts and collaborations, Hohlbaum is poised to leave a lasting impact on the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…